This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Alomone Preclinical Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Nissim Bajayo: Innovator in Spider Venom Research
Introduction
Nissim Bajayo is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of biochemistry, particularly through his research on spider venom. His work focuses on the potential medical applications of isolated peptides derived from spider venom.
Latest Patents
Nissim Bajayo holds a patent for "Peptides isolated from spider venom, and uses thereof." This patent describes isolated spider venom peptides that serve as potent and selective ion channel blockers. These peptides have promising applications in the treatment of pain, showcasing the potential of natural compounds in medical therapies. He has 1 patent to his name.
Career Highlights
Bajayo is associated with Alomone Preclinical Ltd., a company that specializes in the development of innovative solutions in the field of neuroscience and pharmacology. His work at Alomone has allowed him to explore the therapeutic potential of spider venom, contributing to advancements in pain management.
Collaborations
Throughout his career, Nissim has collaborated with talented individuals such as Alon Meir and Ronit Simcha Cherki. These collaborations have fostered a creative environment that encourages innovative research and development.
Conclusion
Nissim Bajayo's research on spider venom peptides represents a significant advancement in the field of pain treatment. His contributions highlight the importance of exploring natural sources for medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile